---
figid: PMC4310451__JDR2015-648239.003
figlink: /pmc/articles/PMC4310451/figure/fig3/
number: F3
caption: Differential effects of leptin and adiponectin in vascular endothelium. Dual
  effects of gAD and fAD on endothelium with and without inflammatory stimuli. Circulating
  fAD gets cleaved by leucocyte elastase (secreted from neutrophils) releasing globular
  domain (gAD) fraction. AdipoR1 and AdipoR2 receptors following engagement with fAD,
  signals downstream activating the following pathways (a) AMPK, (b) cAMP-PKA, (c)
  MAPK, and (d) PI3K-Akt. Activation of cAMP-PKA/AMPK causes increased NO production,
  decreased ROS generation, suppression of NF-κβ pathway leading to reduction in IL-18,
  and endothelial adhesion molecule expression. These events collectively lead to
  a decrease in EC permeability, motility, and migration. Activation of AMPK/PI-3k/Akt
  signalling pathway specifically leads to eNOS phosphorylation and NO release. In
  vitro studies have shown that gAD independently activates NF-κβ via AdipoR1/AMPK-Akt
  pathway. Proangiogenic/inflammatory effects of gAD have been shown to involve AMPK-Akt
  pathways. However, these pathways (AMPK-Akt) also contribute to an opposite effect
  of gAD in coexisting states of hyperglycaemia and inflammation. In hyperglycaemic
  and hyperinsulinaemic states, gAD improves endothelial dysfunction via activation
  of Akt-AMP-eNOS pathways and suppression of endothelial ROS generation via inhibition
  of NF-κβ signalling. The binding of leptin to its receptor (OB-Rb) leads to the
  phosphorylation of Ob-R/JAK2 complex. Subsequent activation of downstream signalling
  cascades including PI3k/Akt-STAT3 activation results in transcription of genes [MCP-1,
  TNF-α, IL-6/-2, and endothelin-1] involved in proatherogenic/angiogenic and inflammatory
  effects, potentiating endothelial proliferation. Additionally, leptin signalling
  in ECs also activates endothelial cell adhesion molecules, MMPs, and VEGF resulting
  in impaired endothelium-dependent vasodilatation promoting hypertension and atherosclerosis.
pmcid: PMC4310451
papertitle: Differential Effects of Leptin and Adiponectin in Endothelial Angiogenesis.
reftext: Raghu Adya, et al. J Diabetes Res. 2015;2015:648239.
pmc_ranked_result_index: '78439'
pathway_score: 0.9239936
filename: JDR2015-648239.003.jpg
figtitle: Differential effects of leptin and adiponectin in vascular endothelium
year: '2015'
organisms:
- Mus musculus
- Rattus norvegicus
- Saccharomyces cerevisiae
- Homo sapiens
- Bos taurus
ndex: 86e317f6-dec3-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC4310451__JDR2015-648239.003.html
  '@type': Dataset
  description: Differential effects of leptin and adiponectin in vascular endothelium.
    Dual effects of gAD and fAD on endothelium with and without inflammatory stimuli.
    Circulating fAD gets cleaved by leucocyte elastase (secreted from neutrophils)
    releasing globular domain (gAD) fraction. AdipoR1 and AdipoR2 receptors following
    engagement with fAD, signals downstream activating the following pathways (a)
    AMPK, (b) cAMP-PKA, (c) MAPK, and (d) PI3K-Akt. Activation of cAMP-PKA/AMPK causes
    increased NO production, decreased ROS generation, suppression of NF-κβ pathway
    leading to reduction in IL-18, and endothelial adhesion molecule expression. These
    events collectively lead to a decrease in EC permeability, motility, and migration.
    Activation of AMPK/PI-3k/Akt signalling pathway specifically leads to eNOS phosphorylation
    and NO release. In vitro studies have shown that gAD independently activates NF-κβ
    via AdipoR1/AMPK-Akt pathway. Proangiogenic/inflammatory effects of gAD have been
    shown to involve AMPK-Akt pathways. However, these pathways (AMPK-Akt) also contribute
    to an opposite effect of gAD in coexisting states of hyperglycaemia and inflammation.
    In hyperglycaemic and hyperinsulinaemic states, gAD improves endothelial dysfunction
    via activation of Akt-AMP-eNOS pathways and suppression of endothelial ROS generation
    via inhibition of NF-κβ signalling. The binding of leptin to its receptor (OB-Rb)
    leads to the phosphorylation of Ob-R/JAK2 complex. Subsequent activation of downstream
    signalling cascades including PI3k/Akt-STAT3 activation results in transcription
    of genes [MCP-1, TNF-α, IL-6/-2, and endothelin-1] involved in proatherogenic/angiogenic
    and inflammatory effects, potentiating endothelial proliferation. Additionally,
    leptin signalling in ECs also activates endothelial cell adhesion molecules, MMPs,
    and VEGF resulting in impaired endothelium-dependent vasodilatation promoting
    hypertension and atherosclerosis.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - STAT3
  - PGF
  - VEGFB
  - MAPK13
  - VEGFA
  - PIK3R3
  - VCAM1
  - IL2
  - MAPK12
  - PRKAA1
  - CCL2
  - VEGFC
  - AKT3
  - GAD1
  - PRKAA2
  - PIK3CA
  - MAPK9
  - MAPK10
  - MAPK11
  - ADIPOQ
  - ADIPOR2
  - FGF2
  - VEGFD
  - PRKAG3
  - MMP2
  - PRKAB1
  - PRKAB2
  - PRKAG1
  - PIK3R6
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - IRS2
  - NFKB1
  - MAPK3
  - NELFCD
  - TNF
  - PRKAG2
  - AKT2
  - MAPK1
  - AKT1
  - JAK2
  - MAPK14
  - PIK3R5
  - MAPK8
  - PIK3R4
  - IL6
  - CRP
  - glucose
genes:
- word: STAT3
  symbol: STAT3
  source: hgnc_symbol
  hgnc_symbol: STAT3
  entrez: '6774'
- word: FGF-2/VEGF/TIMPS
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: PGF
  entrez: '5228'
- word: FGF-2/VEGF/TIMPS
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFB
  entrez: '7423'
- word: AMPK,MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK13
  entrez: '5603'
- word: FGF-2/VEGF/TIMPS
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFA
  entrez: '7422'
- word: PI3-K/Akt
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: VCAM-1,
  symbol: VCAM1
  source: hgnc_symbol
  hgnc_symbol: VCAM1
  entrez: '7412'
- word: MCP-1,TNF-a,IL-6,NF-KB,TNF-a,IL-2,IL-6,
  symbol: IL-2
  source: hgnc_alias_symbol
  hgnc_symbol: IL2
  entrez: '3558'
- word: AMPK,MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK12
  entrez: '6300'
- word: AMPK,MAPK
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAA1
  entrez: '5562'
- word: MCP-1,TNF-a,IL-6,NF-KB,TNF-a,IL-2,IL-6,
  symbol: MCP-1
  source: hgnc_alias_symbol
  hgnc_symbol: CCL2
  entrez: '6347'
- word: FGF-2/VEGF/TIMPS
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFC
  entrez: '7424'
- word: PI3-K/Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: gAD
  symbol: GAD
  source: hgnc_prev_symbol
  hgnc_symbol: GAD1
  entrez: '2571'
- word: AMPK,MAPK
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAA2
  entrez: '5563'
- word: PI3-K/Akt
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: AMPK,MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK9
  entrez: '5601'
- word: AMPK,MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK10
  entrez: '5602'
- word: AMPK,MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK11
  entrez: '5600'
- word: Adiponectin
  symbol: adiponectin
  source: hgnc_alias_symbol
  hgnc_symbol: ADIPOQ
  entrez: '9370'
- word: AdipoR2
  symbol: ADIPOR2
  source: hgnc_symbol
  hgnc_symbol: ADIPOR2
  entrez: '79602'
- word: FGF-2/VEGF/TIMPS
  symbol: FGF2
  source: hgnc_symbol
  hgnc_symbol: FGF2
  entrez: '2247'
- word: FGF-2/VEGF/TIMPS
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFD
  entrez: '2277'
- word: AMPK,MAPK
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAG3
  entrez: '53632'
- word: MMP-2/MMP-9
  symbol: MMP2
  source: hgnc_symbol
  hgnc_symbol: MMP2
  entrez: '4313'
- word: AMPK,MAPK
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAB1
  entrez: '5564'
- word: AMPK,MAPK
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAB2
  entrez: '5565'
- word: AMPK,MAPK
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAG1
  entrez: '5571'
- word: PI3-K/Akt
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: PI3-K/Akt
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: PI3-K/Akt
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: PI3-K/Akt
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: JAK2/IRS2/
  symbol: IRS2
  source: hgnc_symbol
  hgnc_symbol: IRS2
  entrez: '8660'
- word: MCP-1,TNF-a,IL-6,NF-KB,TNF-a,IL-2,IL-6,
  symbol: NF-kappaB
  source: hgnc_alias_symbol
  hgnc_symbol: NFKB1
  entrez: '4790'
- word: AMPK,MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: VCAM-1,endothelin-1MCP-1,ROS,Th1,TGF-ß
  symbol: TH1
  source: hgnc_alias_symbol
  hgnc_symbol: NELFCD
  entrez: '51497'
- word: MCP-1,TNF-a,IL-6,NF-KB,TNF-a,IL-2,IL-6,
  symbol: TNF-alpha
  source: hgnc_alias_symbol
  hgnc_symbol: TNF
  entrez: '7124'
- word: AMPK,MAPK
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAG2
  entrez: '51422'
- word: PI3-K/Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: AMPK,MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: PI3-K/Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: JAK2/IRS2/
  symbol: JAK2
  source: hgnc_symbol
  hgnc_symbol: JAK2
  entrez: '3717'
- word: AMPK,MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK14
  entrez: '1432'
- word: PI3-K/Akt
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: AMPK,MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK8
  entrez: '5599'
- word: PI3-K/Akt
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: MCP-1,TNF-a,IL-6,NF-KB,TNF-a,IL-2,IL-6,
  symbol: IL-6
  source: hgnc_alias_symbol
  hgnc_symbol: IL6
  entrez: '3569'
- word: gAD+inflammatorystimuli(glucose,CRP)
  symbol: CRP
  source: hgnc_symbol
  hgnc_symbol: CRP
  entrez: '1401'
chemicals:
- word: glucose
  source: MESH
  identifier: D005947
diseases: []
figid_alias: PMC4310451__F3
redirect_from: /figures/PMC4310451__F3
figtype: Figure
---
